Humanigen Isn’t Throwing In The Towel On Lenzilumab For COVID-19 Just Yet

 
• By Alaric DeArment

The company is assessing a potential path forward in COVID-19 for the drug and is in talks with platform study groups after a Phase III study did not show statistical significance, but still showed activity.

Humanigen announced preliminary results of a Phase III study of lenzilumab in COVID-19 • Source: Shutterstock

More from COVID-19

More from Scrip